End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.3 SEK | +0.70% | +1.41% | +29.64% |
Apr. 22 | EQL Pharma AB Announces Mellozzan Launched in Germany and Austria | CI |
Feb. 13 | EQL Pharma AB Provides Sales Guidance for the Year 2023/24 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+29.64% | 115M | |
-31.97% | 10.84B | |
+8.14% | 6.04B | |
-11.41% | 5.86B | |
-30.42% | 6.06B | |
-0.88% | 4.71B | |
+52.19% | 4.29B | |
-12.31% | 3.61B | |
-14.86% | 3.33B | |
-6.93% | 3.01B |
- Stock Market
- Equities
- EQL Stock
- News EQL Pharma AB
- Sweden’s EQL Pharma Increases Bid for Sensidose